Darsiya Krishnathasan: Superficial Vein Thrombosis Review in JAMA Provides Practical Guidance
Darsiya Krishnathasan, Research Assistant at Brigham and Women’s Hospital, shared a post on LinkedIn:
“Superficial vein thrombosis is a clinically significant venous thromboembolic disorder, where limited trial data and sparse guidelines leave important gaps in care. Excited to share our JAMA review, which provides practical guidance for clinicians and patients navigating the challenges of superficial vein thrombosis. Inspired by my MBS thesis at Tufts University School of Medicine, this project has been an extraordinary journey, guided by the mentorship of Dr. Gregory Piazza and Dr. Behnood Bikdeli and supported by an amazing team.”
Title: Superficial Vein Thrombosis: A Review
Authors: Gregory Piazza, MD, MS; Darsiya Krishnathasan, MS; Nada Hamade, MPH; Francisco Ujueta, MD, MS; Giovanni Scimeca, MD; Marcos D. Ortiz-Rios, MD; Bridget McGonagle, BS; Jean-Philippe Galanaud, MD, PhD; David Jiménez, MD, PhD; Manuel Monreal, MD, PhD; John Fanikos, RPh, MBA; Anahita Dua, MD, MBA, MSc; Leben Tefera, MD; Raghu Kolluri, MD; Sahil A. Parikh, MD; Walter Ageno, MD; Samuel Z. Goldhaber, MD; Jeffrey I. Weitz, MD; Lisa K. Moores, MD; Isabelle Quéré, MD, PhD; Behnood Bikdeli, MD, MS

Read full article here.
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial